Focus on Haemostasis

5ème tome de la collection « Practical Manual en Hémostase » Stago

5th volume in Stago’s “Practical Manual in Haemostasis” collection

The last two volumes were devoted to anticoagulants (parenteral, then oral), it made sense that the Clinical Development Department had to turn its attention to another side with the exploration of bleeding disorders.

Read more
La dématérialisation continue chez Stago !

Stago continues to ditch paper!

In April 2017, Stago officially launched its IFU (Instruction for Use) platform at www.stago.com so that customers worldwide could visit and download reagent instructions, analyser reference manuals and safety data sheets that they need for their day-to-day work.

Read more
4th booklet in Stago’s “Practical Manual” collection: Oral anticoagulants

4th booklet in Stago’s “Practical Manual” collection: Oral anticoagulants

After the 3rd volume devoted to parental anticoagulants, it stands to reason that the Clinical Development Department had to turn its attention to the other side of anticoagulant treatment – the oral anticoagulants - in this series launched in 2014 with the objective of publishing a Practical Manual each year.

Read more
2017 American Association for Clinical Chemistry (AACC)

2017 American Association for Clinical Chemistry (AACC)

Stago hosted a record-breaking exhibition and charitable event at the 2017 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in San Diego, CA from August 1st through August 3rd. With more than 21,000 attendees and 730 exhibitors, the 2017 AACC expo was the largest yet.

Read more
D-Dimer for the Exclusion of Thromboembolism (DiET) Study Completed STA® - Liatest® D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion

D-Dimer for the Exclusion of Thromboembolism (DiET) Study Completed STA® - Liatest® D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion

December 22, 2016, Parsippany, NJ, USA – On December 10th, 2016 the US Food and Drug Administration (FDA) cleared STA® - Liatest® D-Di for the exclusion of the diagnosis of deep vein thrombosis (DVT) on data reported from the multi-national, DiET study. Clearance for exclusion of the diagnosis of pulmonary embolism (PE) was received in 2014.

Read more